Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mereo Biopharma Group Plc

2.50
+0.09003.73%
Post-market: 2.500.00000.00%16:05 EDT
Volume:1.30M
Turnover:3.23M
Market Cap:397.50M
PE:-8.55
High:2.55
Open:2.47
Low:2.42
Close:2.41
Loading ...

Mereo BioPharma Group PLC expected to post a loss of 1 penny a share - Earnings Preview

Reuters
·
10 May

European Equities Traded in the US as American Depositary Receipts Marginally Higher in Monday Trading

MT Newswires Live
·
05 May

Big Hits: Riversgold, Resouro, Indian Resources and Chilwa

The Sydney Morning Herald
·
05 May

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading

MT Newswires Live
·
22 Apr

European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading

MT Newswires Live
·
21 Apr

European Equities Traded in the US as American Depositary Receipts Modestly Higher in Thursday Trading

MT Newswires Live
·
17 Apr

Mereo BioPharma Group plc (MREO): A Bull Case Theory

Insider Monkey
·
17 Apr

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
14 Apr

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading

MT Newswires Live
·
09 Apr

Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Needham

Dow Jones
·
09 Apr

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
08 Apr

St George delivers maiden Brazil niobium and rare earths resource

The West Australian
·
01 Apr

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading

MT Newswires Live
·
28 Mar

Mereo BioPharma Group Initiated at Overweight by JP Morgan

Dow Jones
·
27 Mar

JPMorgan Initiates Coverage on Mereo BioPharma Group With Overweight Rating, $7 Price Target

MT Newswires Live
·
27 Mar

Mereo Biopharma Group Plc : JP Morgan Initiates Coverage With Overweight Rating; Price Target $7

THOMSON REUTERS
·
27 Mar

Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Needham

Dow Jones
·
26 Mar

Mereo BioPharma Group Q4 2024 GAAP EPS $(0.06) Beats $(1.03) Estimate

Benzinga
·
26 Mar

Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights

GlobeNewswire
·
26 Mar